efficacy omega num fatty acid supplements eicosapentaenoic acid docosahexaenoic acid secondary prevention cardiovascular disease pubmed ncbi abstract background previous randomized double-blind placebo-controlled trials reported efficacy omega num fatty acid supplements secondary prevention cardiovascular disease cvd evidence remains inconclusive meta-analysis investigated efficacy eicosapentaenoic acid docosahexaenoic acid secondary prevention cvd methods searched pubmed embase cochrane library april num independently reviewed selected eligible randomized controlled trials results num articles retrieved num randomized double-blind placebo-controlled trials involving num patients history cvd included final analyses supplementation omega num fatty acids reduce risk cardiovascular events relative risk num num ci num num all-cause mortality sudden cardiac death myocardial infarction congestive heart failure transient ischemic attack stroke small reduction cardiovascular death relative risk num num ci num num disappeared excluded study major methodological problems significant preventive effect observed subgroup analyses country location inland coastal geographic area history cvd concomitant medication type placebo material trial methodological quality trial duration treatment dosage eicosapentaenoic acid docosahexaenoic acid fish oil supplementation treatment conclusion meta-analysis showed insufficient evidence secondary preventive effect omega num fatty acid supplements cardiovascular events patients history cardiovascular disease 
